Your session is about to expire
← Back to Search
Immunotoxin for Brain Tumor
Study Summary
This trial is studying a molecule that may help locate and kill brain tumor cells without harming normal cells.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Find a Location
Who is running the clinical trial?
Media Library
- My brain tumor is small enough and in a place that can be targeted with precise radiation.It has been over 4 weeks since my last radiation treatment.I have undergone external beam radiotherapy before.I can care for myself but may not be able to do active work.I do not have any infections that need treatment.It has been over 4 weeks since my last chemotherapy session.My diagnosis is recurrent glioblastoma or anaplastic astrocytoma.My condition does not involve severe swelling or pressure inside my skull.I am over 18 years old.My cancer has not spread to my brainstem, cerebellum, or across both sides of my brain.I am not receiving any blood or platelet transfusions currently.I have recently had brain surgery.My brain scan shows no widespread disease along the brain's lining or in the fluid.My recent scans show my cancer is growing despite being on steroids.I do not have anaplastic oligodendroglioma.I don't have any illnesses that make surgery too risky.I do not have a fever without a known cause.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this research endeavor enlisting any new participants presently?
"The information hosted on clinicaltrials.gov suggests this trial is no longer actively recruiting, with the initial posting dating back to March 1st 1999 and last update being December 17th 2013. Nonetheless, at the present moment there are 192 other studies that are enrolling patients."
Is this therapy deemed to be a secure option for individuals?
"Our experts at Power rate this treatment's safety as a 1 due to it being in Phase 1 of the clinical trial process. As such, there is limited data available on both its efficacy and security."
To what extent are healthcare facilities administering this experiment?
"Subjects are being enrolled in this trial at UCSF Cancer Center and the Cancer Research Institute, located San Francisco California. Additionally, North carolina Neuro-Oncology Service (Charlotte), Maryland Charlotte Neurosurgical Associates (Bethesda) and 10 other sites across the US are also participating."
Share this study with friends
Copy Link
Messenger